Interleukin 1 in the brain: Biology, pathology and therapeutic target

Trends in Neurosciences

Volumn 23, Issue 12, 2000, Pages 618-625

  Rothwell, Nancy J ^a   Luheshi, Giamal N ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ALZHEIMER DISEASE; ANOREXIA; BRAIN DISEASE; CELL FUNCTION; DEGENERATIVE DISEASE; ENDOTHELIUM CELL; FEVER; HEAD INJURY; HOST RESISTANCE; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NEUROENDOCRINE SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SLOW WAVE SLEEP; STROKE;

ANIMALS; BRAIN; HUMANS; INTERLEUKIN-1; NEURODEGENERATIVE DISEASES; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION;

EID: 0034534995     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01661-1     Document Type: Review

References (97)

1. Cytokines and the nervous system. I: Expression and recognition
2. Cytokines and the nervous system II: Actions and mechanisms of action
3. The pyrogenic and mitogenic actions of interleukin-1 are related
4. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
5. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
6. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types
7. Interleukin 1 signaling occurs exclusively via the type I receptor
8. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
9. Endogenous interleukin-1 receptor antagonist is neuroprotective
10. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes
11. A newly defined interleukin-1?
12. Interleukin-18 and interleukin-1β: Two cytokine substrates for ICE (caspase 1)
13. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme
14. Cloning of rat brain interleukin-18 cDNA
15. Detection of the interleukin 18 family in rat brain by RT-PCR
16. Cultures of astrocytes and microglia express interleukin 18
17. Murine microglial cells produce and respond to interleukin-18
18. Differential induction of interleukin-12, interleukin-18, and interleukin-1β converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat
19. Four new members expand the interleukin-1 superfamily
20. Identification and initial characterization of four novel members of the interleukin-1 family
21. 'Inflammatory' cytokines: Neuro-modulators in normal brain?
22. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
23. The progression and topographic distribution of interleukin-1β expression after permanent middle cerebral artery occlusion in the rat
24. Excitotoxic brain damage in the rat induces interleukin-1β protein in microglia and astrocytes: Correlation with the progression of cell death
25. Constitutive expression of interleukin-1β (IL-1β) in rat oligodendrocytes
26. The differential production of three forms of IL-1 receptor antagonist by human neutrophils and monocytes
27. Receptors for purines and pyrimidines
28. Kinetics and mechanism of ATP-dependent IL-1beta release from microglial cells
29. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion
30. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
31. The interleukin-1 system: Receptors, ligands, and ICE in the brain and their involvement in the fever response
32. Interleukin 1-receptor antagonist blocks interleukin 1-induced sleep and fever
33. Sleep. A physiologic role for IL-1β and TNF-α
34. Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
35. A neuromodulatory role of interleukin-1β in the hippocampus
36. Effects of an interleukin-1β analogue [Lys-D-Pro-Thr], on incomplete cerebral ischemia-induced inhibition of long-term potentiation in rat hippocampal neurons in vivo
37. The interleukin-1 system: Receptors, ligands, and ICE in the brain and their involvement in the fever response
38. Neural-immune interactions in health and disease
39. Leptin and the regulation of body weight in mammals
40. Positional cloning of the mouse obese gene and its human homologue
41. Leptin actions on food intake and body temperature are mediated by IL-1
42. The role of interleukin 1 in acute neurodegeneration and stroke: Pathophysiological and therapeutic implications
43. Annual review prize lecture cytokines-killers in the brain?
44. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion
45. Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothalamic neurons
46. Interleukin-6 is a centrally acting endogenous pyrogen in the rat
47. Fever: Role of pyrogens and cryogens
48. Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat
49. Role of the OVLT in the febrile response to circulating pyrogens
50. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action
51. Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat
52. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia
53. Central action sites of interleukin-1β for inducing fever in rabbits
54. Interleukin-1 induces slow-wave sleep at the prostaglandin D2-sensitive sleep-promoting zone in the rat brain
55. CRF is involved in the pyrogenic and thermogenic effects of interleukin 1β in the rat
56. Mechanisms of the behavioral effects of interleukin 1. Role of prostaglandins and CRF
57. Further studies of the role of hyperthermia in methamphetamine neurotoxicity
58. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury
59. Dissociation between the effects of interleukin-1 on excitotoxic brain damage and body temperature in the rat
60. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: Involvement of nerve growth factor
61. Cytokines in neurodegeneration and repair
62. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat
63. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain
64. The contrasting roles of ICE family proteases and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation
65. Roles of Bcl-2 and caspases in hypoxia-induced neuronal cell death: A possible neuroprotective mechanism of peptide growth factors
66. Involvement of caspase 1 proteases in hypoxic brain injury. Effects of their inhibitors in developing neurons
67. Cytokine interactions and cytokine balance in the brain: Relevance to neurology and psychiatry
68. Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders
69. Caspase 1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase
70. Functional role of caspase 1 and caspase-3 in an ALS transgenic mouse model
71. Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis
72. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
73. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats
74. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus
75. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1α immunoreactivity
76. Interleukin (IL)1β, IL-1α, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy
77. Hematolymphopoietic and inflammatory cytokines in neural development
78. Acute-phase cytokines IL-1β and TNF-α in brain development
79. Autoregulation of the interleukin-1 system and cytokine-cytokine interactions in primary human astrocytoma cells
80. Central nervous system IL-1β system and neuropeptide Y mRNAs during IL-1β-induced anorexia in rats
81. Gram-negative and gram-positive bacterial products induce differential cytokine profiles in the brain: Analysis using an integrative molecular-behavioral in vivo model
82. Induction of interleukin-1β-converting enzyme (ICE) in murine microglia by lipo-polysaccharide
83. Regulation of ICE activity and ICE isoforms by LPS
84. Effects of lipopolysaccharide and gluco-corticoids on expression of interleukin-1β converting enzyme in the pituitary and brain of mice
85. The IL-1 receptor/toll-like receptor superfamily: Crucial receptors for inflammation and host defense
86. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats
87. Cerebral hypoxia-ischemia stimulates cytokine gene expression in perinatal rats
88. Involvement of caspase 1 proteases in hypoxic brain injury. Effects of their inhibitors in developing neurons
89. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage
90. Quantitative changes in interleukin proteins following focal stroke in the rat
91. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells
92. ATP treatment of human monocytes promotes caspase 1 maturation and externalization
93. Regulation of cytokine gene expression in the central nervous system by glucocorticoids: Mechanisms and functional consequences
94. Lipocortin-1: Cellular mechanisms and clinical relevance
95. IL-10 as a mediator in the HPA axis and brain
96. Constitutive and cytokine-inducible expression of prion protein gene in human neural cell lines
97. Interleukin-4 and interleukin-10 regulate IL-1β induced mouse primary astrocyte activation: A comparative study